Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Italy
/
Healthcare
/
EL.En
ELN
EL.En
Accelerating Laser Adoption Will Spur Expansion Despite Tariff Risks
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
17 Jul 25
Updated
23 Jul 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
€14.70
21.8% undervalued
intrinsic discount
23 Jul
€11.50
Loading
1Y
24.3%
7D
-7.0%
Author's Valuation
€14.7
21.8% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
€14.7
21.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
693m
2014
2017
2020
2023
2025
2026
2028
Revenue €693.3m
Earnings €71.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
5.68%
Medical Equipment revenue growth rate
0.32%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
9.78%
Calculation
€71.66m
Earnings '28
x
21.74x
PE Ratio '28
=
€1.56b
Market Cap '28
€1.56b
Market Cap '28
/
80.04m
No. shares '28
=
€19.46
Share Price '28
€19.46
Share Price '28
Discounted to 2025 @ 9.82% p.a.
=
€14.69
Fair Value '25